FDA says approves Gilead’s four-drug HIV treatment

(Reuters) – U.S. health regulators on Monday approved Gilead Sciences Inc’s four-drug combination treatment for HIV, the virus that causes AIDS. The four-drugs in one pill treatment, which was formerly called the Quad and widely considered one of Gilead’s more important future growth drivers, will be sold under the brand name Stribild, the U.S. Food and Drug Administration said. Stribild, a once daily treatment, contains two previously approved HIV medicines and two new drugs. (Reporting by Bill Berkrot; Editing by Bernard Orr)
Sexual Health News Headlines – Yahoo! News